Legal and retail gurus explain how Schedule 3 could impact marijuana sales

November 15, 2023 · MJ Biz Daily

If marijuana is moved from Schedule 1 to Schedule 3 of the Controlled Substances Act, that would expand both access and product selection for medical marijuana patients.

But rescheduling likely wouldn’t impact how state-regulated MMJ dispensaries operate.

“Schedule 3 allows essentially a new pathway for cannabis to be in the marketplace, which is through an FDA-approved drug channel,” said Amy Rubenstein, a partner with the international law firm Dentons.

Pharma pipeline

Rubenstein explained that moving marijuana to Schedule 3 would make it easier for companies to develop cannabis-based drugs and get U.S. Food and Drug Administration approval for them.

Once drugs have FDA approval, they can be purchased with a physician’s prescription at federally licensed pharmacies.

She added that developing drugs, going through the requisite studies and getting approval takes years, so it would be a long time before consumers are able to shop at pharmacies for federally approved, marijuana-based drugs.

Medical marijuana patients, however, could continue to buy regulated cannabis products from state-licensed dispensaries.

And state-regulated recreational marijuana retail owners would be able to operate without fear that federal authorities would crack down on their operations, observers said.

“The state-legal markets are not going to disappear,” Rubenstein said.

‘Significant undertaking’

Justin Brandt, partner with Scottsdale, Arizona-based law firm Bianchi & Brandt, agreed.

“I think at some point it’s possible that we’ll see (medical marijuana products) in pharmacies,” he said.

“But even when cannabis is at Schedule 3, companies or whoever wants to sell under the purview of the FDA/federal law, they’re going to have to go through clinical trials and will have to do the same steps that Big Pharma goes through in getting an FDA-approved drug to market.

“That is a significant undertaking. It costs a lot of money. It takes a significant amount of time. We’re talking years. So, we’re quite a few years away from something like that.”

Flower stays put

While the FDA could eventually approve medical marijuana, don’t expect the agency to approve flower or other combustible products, experts warned.

“I can see it being sold in pharmacies, but I think it would have to be in a different form factor,” said Vince Ning, CEO of California marijuana distributor Nabis.

“I just don’t see a pharmacy or a Kaiser Permanente selling cannabis flower. It’ll probably be in a pressed-pill form or something that’s a medical-grade, concentrated product.”

Ning added: “I think dispensaries will still exist. I hope that direct-to-consumer channels also start to open up. I think that there needs to be more access to channels, because that’s what will help eradicate the illicit market.” (Full Story)

In categories:Federal Policy Legal Retail
Next Post

Florida Supreme Court Poised to Allow Cannabis Legalization Ballot Question in 2024

The Florida Supreme Court seems poised to allow an adult-use cannabis legalization proposal to be put to voters next year, seemingly rejecting the arguments by state Attorney General Ashley Moody that the initiative’s wording is misleading and that it violates the state’s…
Read
Previous Post

Will rescheduling reroute the future of interstate commerce for cannabis?

Some cannabis executives are hopeful that if the federal government moves marijuana from Schedule 1 to 3 of the Controlled Substances Act, then transporting MJ products across state lines will be allowed. But that is only partially true, marijuana industry…
Read
Random Post

Canadian producers report 2,200 kilograms of lost or stolen cannabis since 2018

An increasing amount of cannabis grown by licensed Canadian producers has been lost or stolen over the past five years, new data shared with MJBizDaily shows. Separate data provided by Health Canada, the department responsible for federal health policy, also…
Read
Random Post

North Carolina Senate Approves Medical Marijuana Regulatory Appointment As House Leader Says ‘Heavy-Handed’ Tactics Not Helping Legalization’s Fate

A Republican North Carolina senator is making it clear that he intends to see his medical marijuana legalization bill pass this session despite some obstinance among GOP leadership in the House—and he’s even gone so far as to include medical…
Read
Random Post

The Struggle is Real for Republicans and Legal Cannabis in America

Schizophrenia and cannabis made the news this week as a new study shows young men who use cannabis at a high frequency may have higher trends towards schizophrenia.  The study may want to look at Repubilcan politicians in US as well,…
Read
Random Post

Federal Judge Allows Lawsuit About Religious Use of Hallucinogenic Tea to Move Forward

Parties exchanged legal barbs over religious freedom and the Controlled Substances Act. A U.S. federal judge ruled that a lawsuit by an Arizona religious group seeking legal approval to use a hallucinogenic tea in its rituals can proceed. The Arizona…
Read